JOSEPH NORRIS: Open Payments
NPI 1346247905 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$621 in 32 payments from 11 companies in 2025. Trend: 2023 $112 · 2024 $205 · 2025 $621
Food & beverage: $621
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $169 |
| ABBVIE INC. | 6 | $118 |
| Lilly USA, LLC | 5 | $95 |
| Astellas Pharma US Inc | 4 | $88 |
| Catalyst OrthoScience | 1 | $47 |
| Hologic Sales and Service, LLC | 1 | $22 |
| Verona Pharma, Inc. | 1 | $21 |
| Currax Pharmaceuticals LLC | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| PFIZER INC. | 1 | $15 |
Products named: Wegovy, Veozah, UBRELVY, MOUNJARO, QULIPTA, ZEPBOUND, APTIMA, Ohtuvayre.
Industry payments across PA — which companies pay providers there.
